Julie Hambleton, EVP & Chief Medical Officer at FIVE PRIME THERAPEUTICS INC (FPRX), bought 1,764 shares at $10.75 ($22K) on 2014-08-22, disclosed to the SEC on 2015-10-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.75 | 800 | $12K | 53.6% |
| 2 | $13.70 | 64 | $877 | 4.0% |
| 3 | $10.10 | 500 | $5K | 22.9% |
| 4 | $10.75 | 400 | $4K | 19.5% |
| Total | $12.49 avg | 1,764 | $22K | 100% |
| Filing → |
| SWTX | SELL | 2024-06-05 | $302K | — | Filing → |
| SWTX | SELL | 2023-07-21 | $142K | — | Filing → |
| SWTX | SELL | 2023-06-22 | $129K | — | Filing → |